Programmed colorectal cancer screening decreases incidence and mortality.
作者信息
Roselló Susana, Simón Soraya, Cervantes Andrés
机构信息
Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
出版信息
Transl Gastroenterol Hepatol. 2019 Dec 26;4:84. doi: 10.21037/tgh.2019.12.13. eCollection 2019.
Abstract
摘要
相似文献
1
Programmed colorectal cancer screening decreases incidence and mortality.计划性结直肠癌筛查可降低发病率和死亡率。
Transl Gastroenterol Hepatol. 2019 Dec 26;4:84. doi: 10.21037/tgh.2019.12.13. eCollection 2019.
2
Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.英国结直肠癌筛查试点研究对发病率、分期分布和死亡率趋势的影响。
Cancer Epidemiol. 2012 Aug;36(4):e232-42. doi: 10.1016/j.canep.2012.02.006. Epub 2012 Mar 14.
3
Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer.粪便潜血筛查对结直肠癌发病率和死亡率的长期影响。
Dig Liver Dis. 2014 Dec;46(12):1121-5. doi: 10.1016/j.dld.2014.08.041. Epub 2014 Sep 16.
4
Comparisons of colorectal cancer mortality between screening participants and the general population are strongly biased unless an incidence-based mortality approach is used.除非采用基于发病率的死亡率方法，否则对筛查参与者和一般人群的结直肠癌死亡率进行比较会存在严重的偏差。
J Clin Epidemiol. 2014 Feb;67(2):184-9. doi: 10.1016/j.jclinepi.2013.08.017. Epub 2013 Nov 5.
5
Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.荷兰结直肠癌筛查计划对癌症发病率和死亡率的长期影响——基于模型的锯齿状途径探索
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):135-44. doi: 10.1158/1055-9965.EPI-15-0592. Epub 2015 Nov 23.
6
7
Is it reasonable to use faecal occult blood test for colorectal cancer screening?使用粪便潜血试验进行结直肠癌筛查合理吗？
Acta Univ Palacki Olomuc Fac Med. 1999;142:119-21.
8
Changing trends in colorectal cancer in the Republic of Korea: contrast with Japan.韩国结直肠癌的变化趋势：与日本的对比。
Epidemiol Health. 2015 Aug 17;37:e2015038. doi: 10.4178/epih/e2015038. eCollection 2015.
9
The impact of screening on cancer incidence and mortality in Missouri, USA, 2004-2013.2004 - 2013年美国密苏里州筛查对癌症发病率和死亡率的影响。
Public Health. 2018 Jan;154:51-58. doi: 10.1016/j.puhe.2017.10.015. Epub 2017 Dec 1.
10
Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention.系统评价与荟萃分析：阿司匹林与结直肠癌筛查预防的比较效果。
Aliment Pharmacol Ther. 2017 Jan;45(2):193-204. doi: 10.1111/apt.13857. Epub 2016 Nov 17.
引用本文的文献
1
Evaluating the implementation of colorectal cancer screening practices at King Abdul-Aziz Medical City, Riyadh.评估利雅得阿卜杜勒-阿齐兹国王医疗城的结直肠癌筛查实践的实施情况。
J Family Med Prim Care. 2025 Apr;14(4):1352-1358. doi: 10.4103/jfmpc.jfmpc_1512_24. Epub 2025 Apr 25.
2
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada.加拿大艾伯塔省粪便检测阳性后行结肠镜检查的时间与结直肠癌结局的关系。
J Med Screen. 2024 Dec;31(4):232-238. doi: 10.1177/09691413241239023. Epub 2024 Mar 15.
3
16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population.伊朗人群中结直肠癌阳性与结直肠癌阴性患者口腔和粪便微生物群的16S rRNA测序分析
Gut Pathog. 2024 Feb 20;16(1):9. doi: 10.1186/s13099-024-00604-0.
4
miR-6883 downregulates HIF1α in colorectal and breast cancer cells.miR-6883在结肠癌细胞和乳腺癌细胞中下调缺氧诱导因子1α（HIF1α）。
MicroPubl Biol. 2024 Jan 26;2024. doi: 10.17912/micropub.biology.000978. eCollection 2024.
5
Patients' Expectations and Preferences for the Organizational Conditions of the Colorectal Cancer Screening Programme in Poland: A Qualitative Analysis.波兰结直肠癌筛查项目组织条件的患者期望与偏好：一项定性分析
Healthcare (Basel). 2023 Jan 28;11(3):371. doi: 10.3390/healthcare11030371.
6
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.多靶点粪便免疫化学试验与粪便免疫化学试验用于结直肠癌筛查项目：一项具有配对设计的横断面干预研究。
BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2.
7
Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers.组学技术在检测结直肠癌生物标志物中的应用。
Cancers (Basel). 2022 Feb 6;14(3):817. doi: 10.3390/cancers14030817.
8
Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer.通过Wnt/β-连环蛋白信号通路导致的UBE2M过表达与结直肠癌的不良预后和化疗耐药相关。
Transl Cancer Res. 2020 Sep;9(9):5614-5625. doi: 10.21037/tcr-20-2641.
9
Colorectal Cancer Study of Austria (CORSA): A Population-Based Multicenter Study.奥地利结直肠癌研究（CORSA）：一项基于人群的多中心研究。
Biology (Basel). 2021 Jul 28;10(8):722. doi: 10.3390/biology10080722.
10
CircTBL1XR1/miR-424 axis regulates Smad7 to promote the proliferation and metastasis of colorectal cancer.环状TBL1XR1/miR-424轴通过调控Smad7促进结直肠癌的增殖和转移。
J Gastrointest Oncol. 2020 Oct;11(5):918-931. doi: 10.21037/jgo-20-395.
本文引用的文献
1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.基于大型社区人群的结直肠癌筛查对癌症发病率和死亡率的影响。
Gastroenterology. 2018 Nov;155(5):1383-1391.e5. doi: 10.1053/j.gastro.2018.07.017. Epub 2018 Jul 19.
3
The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.年轻人结直肠癌发病率上升对最佳筛查起始年龄的影响：为美国癌症协会结直肠癌筛查指南提供信息的 I 号微观模拟分析
Cancer. 2018 Jul 15;124(14):2964-2973. doi: 10.1002/cncr.31543. Epub 2018 May 30.
4
The IARC Perspective on Colorectal Cancer Screening.国际癌症研究机构对结直肠癌筛查的观点。
N Engl J Med. 2018 May 3;378(18):1734-1740. doi: 10.1056/NEJMsr1714643. Epub 2018 Mar 26.
5
Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.欧盟成员国癌症筛查的实施与组织状况——第二次欧洲筛查报告的总结结果
Int J Cancer. 2018 Jan 1;142(1):44-56. doi: 10.1002/ijc.31043. Epub 2017 Oct 10.
6
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.结直肠癌筛查：美国多学会专家组对医生和患者的建议。
Am J Gastroenterol. 2017 Jul;112(7):1016-1030. doi: 10.1038/ajg.2017.174. Epub 2017 Jun 6.
7
Colorectal cancer screening: Systematic review of screen-related morbidity and mortality.结直肠癌筛查：与筛查相关的发病率和死亡率的系统评价。
Cancer Treat Rev. 2017 Mar;54:87-98. doi: 10.1016/j.ctrv.2017.02.002. Epub 2017 Feb 16.
8
Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers.在美国，结直肠癌是50岁以下成年人癌症发病率和死亡率的主要原因：一项基于监测、流行病学和最终结果（SEER）的分析，并与其他青年发病癌症进行比较。
J Investig Med. 2017 Feb;65(2):311-315. doi: 10.1136/jim-2016-000229. Epub 2016 Nov 18.
9
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.结直肠癌筛查策略的益处、负担及危害评估：美国预防服务工作组的建模研究
JAMA. 2016 Jun 21;315(23):2595-609. doi: 10.1001/jama.2016.6828.
10
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.结直肠癌筛查：美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332.
Zotero 插件